← Back to Patent Explorer
US5405315A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for determining adequacy of dialysis based on urea concentration

Assignee: KHURI SOUMAYA M
•
Filing: 1994-02-15
•
Granted: 1995-04-11
•
Expires: 2014-02-15
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for determining the adequacy of dialysis, using determination of urea concentration in the dialysate effluent with an enzymatic electrode incorporating a urease sensor, and conversion of this information to arterial urea nitrogen utilizing a "flow ratio" correction; and utilizing the arterial blood urea nitrogen derived from readings of an on-line monitoring sensor as an absolute quantity, and the urea reduction ratio as a relative quantity as a new end-point for dialysis adequacy.

Inventors

  • 👤 Raja N. Khuri
  • 👤 Nazih L. Nakhoul

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 11:26
CPC Classifications
A; A61; A61M; A61M1/00; A61M1/14; A61M1/16; A61M1/1601; A61M1/1603; A61M1/1605; A61M1/1609; A61M1/1619; A61M1/36; A61M1/3607; A61M1/3609; A61M2202/00; A61M2202/04; A61M2202/0496; A61M2202/0498; A61M2205/00; A61M2205/15; A61M2205/33; A61M2205/3303

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 84 words
A method for determining adequacy of dialysis of a patient, comprising: (a) providing an enzymatic urease-based sensor; (b) using said sensor to determine a concentration of urea in dialysate from said dialysis; (c) utilizing said urea concentration in said dialysate and selected physiological factors associated with the patient and with said dialysis to accurately determine a concentration of urea in arterial blood and to determine dialysis adequacy; and (d) ceasing dialysis of said patient when said dialysis is adequate as determined in step (c).
Claim 2
Independent Claim 84 words
A method for determining adequacy of dialysis of a patient, comprising: (a) providing an enzymatic urease-based sensor; (b) using said sensor to determine a concentration of urea in dialysate from said dialysis; (c) utilizing said urea concentration in said dialysate and selected physiological factors associated with the patient and with said dialysis to accurately determine a concentration of urea in arterial blood and to determine dialysis adequacy; and (d) ceasing dialysis of said patient when said dialysis is adequate as determined in step (c).
Claim 3
Dependent Claim 28 words
The method of claim 1 including conducting said steps on an ongoing basis and ceasing dialysis of said patient whenever dialysis of said patient is indicated as adequate.
Claim 4
Dependent Claim 30 words
The method for determining adequacy of dialysis of a patient according to claim 1, wherein said selected physiological factors comprise flow rates of venous blood, arterial blood and dialysate fluid.
Claim 5
Independent Claim 120 words
A method for determining adequacy of dialysis of a patient, comprising: (a) providing an enzymatic urease-based sensor; (b) using said sensor to determine a concentration of urea in dialysate from said dialysis; (c) utilizing said urea concentration in said dialysate and selected physiological factors associated with the patient and with said dialysis to accurately determine a concentration of urea in arterial blood and to determine dialysis adequacy; (d) calculating a urea reduction ratio; (e) utilizing the dialysis adequacy as an absolute quantity and the urea reduction ratio as a relative quantity as new end-points to determine when to cease dialysis; and (f) ceasing dialysis of said patient when said dialysis is adequate as determined in step (c) and step (e).
Claim 6
Independent Claim 120 words
A method for determining adequacy of dialysis of a patient, comprising: (a) providing an enzymatic urease-based sensor; (b) using said sensor to determine a concentration of urea in dialysate from said dialysis; (c) utilizing said urea concentration in said dialysate and selected physiological factors associated with the patient and with said dialysis to accurately determine a concentration of urea in arterial blood and to determine dialysis adequacy; (d) calculating a urea reduction ratio; (e) utilizing the dialysis adequacy as an absolute quantity and the urea reduction ratio as a relative quantity as new end-points to determine when to cease dialysis; and (f) ceasing dialysis of said patient when said dialysis is adequate as determined in step (c) and step (e).
Claim 7
Independent Claim 117 words
A method for determining adequacy of dialysis of a patient, comprising: (a) providing an enzymatic urease-based sensor electrode; (b) using said electrode to determine a concentration of urea in dialysate from said dialysis; (c) utilizing said urea concentration in said dialysate to obtain an arterial urea concentration; (d) using said arterial urea concentration to obtain a profile of urea reduction; (e) using said profile to assess dialysis adequacy; (f) calculating a urea reduction ratio; (g) utilizing the dialysis adequacy as an absolute quantity and the urea reduction ratio as a relative quantity to determine when to cease dialysis; and (h) ceasing dialysis of said patient when said dialysis is adequate as determined in steps (e) and (g).
Claim 8
Independent Claim 117 words
A method for determining adequacy of dialysis of a patient, comprising: (a) providing an enzymatic urease-based sensor electrode; (b) using said electrode to determine a concentration of urea in dialysate from said dialysis; (c) utilizing said urea concentration in said dialysate to obtain an arterial urea concentration; (d) using said arterial urea concentration to obtain a profile of urea reduction; (e) using said profile to assess dialysis adequacy; (f) calculating a urea reduction ratio; (g) utilizing the dialysis adequacy as an absolute quantity and the urea reduction ratio as a relative quantity to determine when to cease dialysis; and (h) ceasing dialysis of said patient when said dialysis is adequate as determined in steps (e) and (g).

References Cited (Backward Citations)

US4647378A Cited
US4718891A Cited
US4954444A Cited
US5230702A Cited
US5258314A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-04-10 1998-10-10 1999-04-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-04-10 2002-10-10 2003-04-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-04-10 2006-10-10 2007-04-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag